Philippe Camus, M.D.

Dijon, France

Both apps are now back!

Back to drug

The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

LVIII.ap

Path: Respiratory bronchiolitis (w/wo the RB-ILD-pattern)

Publications

Marlière C, De Greef J, Gohy S, Hoton D, Wallemacq P, Jacquet LM, Belkhir L

Fatal e-cigarette or vaping associated lung injury (EVALI): a first case report in Europe.

The European respiratory journal 2020 Mar 26;; — 2020 Mar 26

Macedonia TV, Krefft SD, Rose CS

Persistent Severe Fixed Airways Obstruction in a High-Dosing E-cigarette User.

Journal of general internal medicine 2019 Nov 08;; — 2019 Nov 08

Flower M, Nandakumar L, Singh M, Wyld D, Windsor M, Fielding D

Respiratory bronchiolitis-associated interstitial lung disease secondary to electronic nicotine delivery system use confirmed with open lung biopsy.

Respirology case reports 2017 05;5;e00230 — 2017 05 — e00230